Antagonists of the human CCR5 receptor as anti-HIV-1 agents. Part 2: structure–activity relationships for substituted 2-aryl-1-[ N -(methyl)- N -(phenylsulfonyl)amino]-4-(piperidin-1-yl)butanes

This publication has 20 references indexed in Scilit:

• Current Evidence and Future Directions for Targeting HIV Entry
  JAMA, 2000
• HIV-1 entry – an expanding portal for drug discovery
  Drug Discovery Today, 2000
• Chemokine Receptor Antagonists
  Medicinal Research Reviews, 2000
• Host factors in the pathogenesis of HIV disease
  Immunological Reviews, 1997
• Coreceptors--Implications for HIV Pathogenesis and Therapy
  Science, 1997
• Human Chemokines: An Update
  Annual Review of Immunology, 1997
• The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression
  Nature Medicine, 1997
• Host factors and the pathogenesis of HIV-induced disease
  Nature, 1996
• Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
  Cell, 1996
• Chemokine Receptors and HIV-1: An Attractive Pair?
  Cell, 1996